A recent analysis utilizing data from the National Health and Nutrition Examination Survey (2007-2016) underscores the compounded risk factors contributing to chronic kidney disease (CKD) among the elderly population in the United States.
Study Overview and Methodology
Researchers examined 13,273 participants, distinguishing between those diagnosed with CKD and those without. The investigation focused on estimated pulse wave velocity (ePWV), a measure of arterial stiffness, and serum Klotho levels, a biomarker associated with aging and kidney function. By employing restricted cubic spline analysis and linear regression models, the study assessed the relationships between these variables and CKD prevalence.
Key Findings and Statistical Outcomes
The findings revealed that individuals with CKD exhibited significantly higher ePWV and lower serum Klotho levels compared to their non-CKD counterparts. A notable negative linear correlation emerged between ePWV and Klotho levels. Furthermore, the interaction between increased ePWV and decreased Klotho markedly elevated the odds of developing CKD, with an odds ratio of 1.847.
• Elevated arterial stiffness combined with lower Klotho levels significantly amplifies CKD risk.
• The negative association suggests that as ePWV increases, Klotho decreases, further escalating kidney disease likelihood.
• Findings remain consistent across various subgroups, indicating the robustness of the interaction effect despite potential confounders.
These results advocate for the integrated assessment of arterial health and Klotho levels in clinical settings. Regular monitoring could enable early identification of at-risk individuals, facilitating timely interventions to mitigate CKD progression.
Understanding the synergy between cardiovascular markers and biochemical indicators like Klotho can enhance preventive strategies in elderly care. Healthcare providers might consider including ePWV and serum Klotho evaluations in routine screenings to better manage and potentially reduce the incidence of chronic kidney disease.
Implementing combined assessments of ePWV and serum Klotho can streamline CKD management protocols, ensuring a holistic approach to patient health. This integrated strategy not only aids in early detection but also paves the way for personalized treatment plans targeting the underlying risk factors.
Continued research should explore the mechanisms linking arterial stiffness and Klotho deficiency, potentially unveiling new therapeutic targets. Enhancing our understanding of these interactions will be pivotal in developing comprehensive strategies to combat CKD in the aging population.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
